Tyler Miller

Graduate Student

MD/PhD, Case Western Reserve University

Moved on to:
Massachusetts General Hospital - Clinical Pathology Residency, Research Track

2012-2016

Tyler graduated from THE Ohio State University with a BS in Biomedical Science in 2010. While at Ohio State, Tyler spent 4 years at the OSU Comprehensive Cancer Center studying the role of microRNAs in Tamoxifen Resistant Breast Cancer. Tyler received his MD and PhD through Case Western's MSTP and is completed his PhD with joint efforts in the labs of Drs. Jeremy Rich and Paul Tesar. His main project was the development of a novel in vivo screening technique to identify new therapeutic targets in glioblastoma, the most common and aggressive primary brain tumor. The findings were published in Nature in July 2017. Tyler is currently a Clinical Pathology Resident at Massachusetts General Hospital where he plans to continue his research on glioblastoma.